Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of the Combined BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

NCT07413705 is registered in ClinicalTrials.gov with BTL Industries Ltd. as lead sponsor.

NCT NCT07413705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07413705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of the Combined BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
Lead sponsor
BTL Industries Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
November 20, 2025
Completion date
December 11, 2026
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

depressive symptoms, sexual dysfunction, urinary incontinence